Drug
Methylprednisolone Hemisuccinate clinical trials
Also written Methylprednisolone Sodium Succinate, Solu-Medrol and A-MethaPred.
- studies test it
- 33
- open now
- 7
- in phase 3
- 8
- first study started
- 2000
Keep track of what changes. Save the Methylprednisolone Hemisuccinate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
33 studies that test it; most in 2020 (5)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 2
- Phase 2
- 13
- Phase 3
- 8
- Phase 4
- 8
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 33
Stanford University (2) · Sohag University (2) · Washington University School of Medicine (1) · Wan-Jin Chen (1) · Mazandaran University of Medical Sciences (1) · University Children's Hospital Basel (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (1)
Often tested with
Tested in the same studies.
Antilymphocyte Serum (3) · Mycophenolic Acid (3) · Rituximab (3) · Dexamethasone (2) · Cyclophosphamide (2) · Cyclosporine (2) · Filgrastim (2) · Tacrolimus (1)
Studies
Open first, then newest update. How each study uses Methylprednisolone Hemisuccinate is read from its arms, and is right about nine times in ten.
Testing it · 33
- IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid HemorrhageRecruitingPhase 2Daniel Raper, MBBSNCT07054801Written as Methylprednisolone sodium succinate
- Methylprednisolone for Stroke With Large Infarct Core and Post-stroke LymphocytopeniaRecruitingPhase 3YiLinNCT07202143Written as Methylprednisolone sodium succinate
- Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STrokeNot yet recruitingNot applicableSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07175649Written as Methylprednisolone sodium succinate
- The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic ArthritisRecruitingPhase 3Sohag UniversityNCT06463379Written as Solumedrol
- Pulse Steroid Injection in Refractory Rheumatoid ArthritisRecruitingPhase 3Sohag UniversityNCT06456489Written as Solumedrol
- Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related HepatitisRecruitingPhase 2Inge Marie SvaneNCT04810156Written as Solu-Medrol
- Sphingosine-1-phosphate and PneumoniaRecruitingPhase 2/3Taipei Medical University WanFang HospitalNCT04007328Written as Methylprednisolone Sodium Succinate
- Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaActive, not recruitingPhase 2Washington University School of MedicineNCT00882895Written as Solumedrol
- Methylprednisolone Adjunctive to Endovascular Thrombectomy for StrokeActive, not recruitingPhase 3Wan-Jin ChenNCT06360458Written as Methylprednisolone sodium succinate
- Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple SclerosisCompletedPhase 2Mazandaran University of Medical SciencesNCT04979650Written as Methylprednisolone succinate
- Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)CompletedPhase 3University Children's Hospital BaselNCT04826588Written as Methylprednisolone sodium succinate 10 mg/kg intravenously
- Genomic Effects of Glucocorticoids in Patients With Systemic Lupus ErythematosusCompletedEarly Phase 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT04233164Written as Solu-Medrol 1mg/kg
- Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19TerminatedPhase 2Hospital Sao DomingosNCT04377503Written as Methylprednisolone Sodium Succinate
- Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)Status unknownPhase 3University of Roma La SapienzaNCT03745664Written as Methylprednisolone Sodium Succinate
- A Comparison of Ultrasound-guided Steroid Injection With Wrist Splint in Carpal Tunnel SyndromeStatus unknownPhase 4Mercy Health OhioNCT04515966Written as Methylprednisolone Injection [Solu-Medrol]
- Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19CompletedPhase 2Fundação de Medicina Tropical Dr. Heitor Vieira DouradoNCT04343729Written as Methylprednisolone Sodium Succinate
- Evaluation of Corticosteroid in Systemic Inflammatory Response SyndromeCompletedPhase 4Assiut UniversityNCT03876041Written as solumedrol
- Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedPhase 1OHSU Knight Cancer InstituteNCT02779283Written as Methylprednisolone Sodium Succinate
- Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With EpilepsyStatus unknownPhase 1/2Louisiana State University Health Sciences Center in New OrleansNCT04219995Written as methylprednisolone sodium succinate
- Allogeneic Transplantation From Related Haploidentical DonorsCompletedPhase 2Stanford UniversityNCT00185692Written as Solumedrol
See all 33 studies that test Methylprednisolone Hemisuccinate →
Given in every arm · 11 — Methylprednisolone Hemisuccinate is usual care beside what is tested
- Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host DiseaseRecruitingPhase 2Bin GuNCT07185633Written as Methylprednisolone sodium succinate
- The Effect of PAP on ISSHL Comorbided With OSARecruitingPhase 4Beijing Tsinghua Chang Gung HospitalNCT04192656Written as Methylprednisolone Hemisuccinate
- Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1CompletedPhase 1The Cooper Health SystemNCT06462781Written as Methylprednisolone sodium succinate
- Genomic Responses of Human Immune and Non-Immune Cells to GlucocorticoidsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02798523Written as Methylprednisolone sodium succinate(Solu-Medrol)
- Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic LeukemiaCompletedPhase 2M.D. Anderson Cancer CenterNCT01319981Written as Solu-Medrol
- Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)CompletedPhase 1/2M.D. Anderson Cancer CenterNCT02464657Written as Solu-medrol
- Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic LeukemiaCompletedPhase 2M.D. Anderson Cancer CenterNCT00671658Written as Solumedrol
- Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AMLTerminatedPhase 3Stanford UniversityNCT00568633Written as Methylprednisolone sodium succinate
- Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHDCompletedPhase 2Stanford UniversityNCT00186628Written as Solumedrol
- Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATGCompletedPhase 2Stanford UniversityNCT00899847Written as Solumedrol
- Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) PatientsTerminatedPhase 1BBB-Therapeutics B.V.NCT02048358Written as Methylprednisolone hemisuccinate
As the comparator · 7 — what is tested is compared with Methylprednisolone Hemisuccinate
- Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee OsteoarthritisNot yet recruitingPhase 2/3DuoGenic StemCells Corporation (DGSC)NCT07703280Written as Solu-Medrol
- Evaluation of Corticosteroid Administration Following Impacted Third Molar Surgery Using 3-Dimensional Facial AnalysisCompletedNot applicableIrfan ÜstündağNCT07628166Written as methylprednisolone sodium succinate
- Phase III Clinical Study of NPB-01 in Patients With Autoimmune EncephalitisStatus unknownPhase 3Nihon Pharmaceutical Co., LtdNCT05177939Written as NPB-01-ME
- The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.CompletedNot applicableNayera Hazaa ElsherifNCT03412188Written as conventional
- Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple SclerosisTerminatedNot applicableUniversity of UtahNCT02296346Written as SoluMedrol
- Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host DiseaseCompletedPhase 1Massachusetts Eye and Ear InfirmaryNCT01977781Written as Methylprednisolone Sodium Succinate
- Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized PatientsCompletedPhase 4Hamamatsu UniversityNCT00627731Written as methylprednisolone sodium succinate (mPSL)
Codes
What other systems call Methylprednisolone Hemisuccinate · ClinicalTrials.gg INT007823
- MeSH (NLM) D008776Methylprednisolone HemisuccinateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5GMR90S4KNMETHYLPREDNISOLONE HEMISUCCINATEConfirmed FDA, NLM, Wikidata
- Wikidata Q27262132methylprednisolone hemisuccinateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87234Methylprednisolone HemisuccinateOne source FDA
- DrugBank DB14644One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008776 | Methylprednisolone Hemisuccinate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5GMR90S4KN | METHYLPREDNISOLONE HEMISUCCINATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27262132 | methylprednisolone hemisuccinate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87234 | Methylprednisolone Hemisuccinate | One source FDA |
| DrugBank | DB14644 | — | One source Wikidata |
Also registered as methylprednisolone sodium succinate (UNII LEC9GKY20K · RxNorm 203189).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.